Multimodal Prehabilitation in Frail and Non-frail Patients Waiting for a Kidney Transplantation (the FRAILMAR Study) (Frailmar)
Primary Purpose
Chronic Kidney Diseases
Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Multimodal prehabilitation
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Kidney Diseases focused on measuring chronic kidney disease, kidney transplantation, frailty, prehabilitation, exercise, nutritional status, psychological advice, sarcopenia
Eligibility Criteria
Inclusion Criteria:
- Adults patients with chronic kidney disease
- Inclusion in the waiting list for deceased donor kidney transplantation in the period September 2020 to August 2022
Exclusion Criteria:
- Patients unable to perform the exercise plan or giving informed consent
Sites / Locations
- Hospital del MarRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Multimodal intervention
Standard Care
Arm Description
supervised physical training (1-hour sessions, 24 sessions, 8 weeks) + nutritional supplementation + psychological advice
Healthy living recommendations
Outcomes
Primary Outcome Measures
Bad-Outcome Composite Endpoint
Delayed draft function >14 days + never functioning kidney + non-elective readmission before day 90 + surgical complications (wound healing problems, obstructive lymphocele, vascular thrombosis, urinary stenosis or leak, acute hemorrhage, immediate re-intervention) + discharge to an assisted facility + all-cause death.
Secondary Outcome Measures
Changes in exercise capacity
Changes in peak oxygen uptake (higher scores mean better outcome)
Changes in peripheral muscle strength
Changes in handgrip and quadriceps muscles strength (higher scores mean better outcome)
Changes in respiratory muscle strength
Changes in maximal inspiratory and expiratory muscle strength (higher scores mean better outcome)
Changes in physical activity
Changes in physical activity assessed by activity monitors (higher scores mean better outcome)
Attendance
Attended sessions (0-100%, patients are expected to attend a minimum of 80% sessions)
Exercise tolerability
Patients not requiring exercise discontinuation or intensity modification
Changes in muscle mass
Changes in muscle mass assessed with total body dual energy X-ray
Changes in mood state
Changes in Hospital Anxiety Depression Scale
Changes in health-related quality of life
Score in the Short-Form 36 questionnaire (8 dimensions scoring 0-100, higher scores mean better outcomes)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04701398
Brief Title
Multimodal Prehabilitation in Frail and Non-frail Patients Waiting for a Kidney Transplantation (the FRAILMAR Study)
Acronym
Frailmar
Official Title
Frailty in Patients With Advanced Chronic Kidney Disease Waiting for a Kidney Transplantation. A Randomized Clinical Trial of Multimodal Prehabilitation.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2020 (Actual)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Parc de Salut Mar
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Frailty is very frequent among patients waiting for a kidney transplantation (KT). Frailty and poor fitness powerfully predict mortality, kidney graft survival, and healthcare utilization after KT. Frailty in patients with chronic kidney disease (CKD) displays a constellation of features that characterize a special population. Intervention is essential to improve quality of life for frail CKD patients, regardless of their age. A pre-transplant intervention including physical therapy, nutritional measures and psychological support scheduled for before the transplant may improve patient retention and compliance, better mitigate the effects of frailty and poor fitness after KT, and improve main outcomes in frail CKD patients.
The main objective is to assess effectiveness, feasibility and safety of a prehabilitation program (exercise, nutritional plans, psychological advice) in frail and non-frail KT candidates on clinical and functional outcomes after KT.
Detailed Description
Frailty is very frequent among patients with chronic kidney disease (CKD) included in the waiting list for deceased donor kidney transplantation (KT), and outcomes are worsened in those frail recipients after KT. Frailty and poor fitness powerfully predict mortality, kidney graft survival, and healthcareutilization after KT. Frailty in CKD patients displays a unique constellation of features such as muscle wasting, anorexia, protein energy wasting, inflammation, oxidative stress, catabolic/anabolic hormone imbalance, metabolic acidosis, and other cellularalterations that characterize a special population. Intervention is essential to improve quality of life for frail CKD patients, regardless of their age. Efforts to intervene with post- transplant physical therapy have been met with limited success, in large part due to high study dropout. A pre-transplant clinical framework for multimodal prehabilitation interventions including physicaltherapy, nutritional measures and psychological support scheduled for before the transplant may improve patient retention andcompliance, better mitigate the effects of frailty and poor fitness after KT, and improve main outcomes in frail CKD patients.
The main objective of this study is to assess effectiveness, feasibility and safety of multimodal prehabilitation (exercise, nutritional plans, psychological advice) in frail and non-frail KT candidates in the context of a randomized controlled clinical trial. The primary endpoint will be a composite achievement of clinical and functional outcomes in frail and non-frail KT candidates after KT.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Diseases
Keywords
chronic kidney disease, kidney transplantation, frailty, prehabilitation, exercise, nutritional status, psychological advice, sarcopenia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Clinical Trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
138 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Multimodal intervention
Arm Type
Experimental
Arm Description
supervised physical training (1-hour sessions, 24 sessions, 8 weeks) + nutritional supplementation + psychological advice
Arm Title
Standard Care
Arm Type
No Intervention
Arm Description
Healthy living recommendations
Intervention Type
Other
Intervention Name(s)
Multimodal prehabilitation
Intervention Description
Exercise + nutritional supplementation + psychological advice
Primary Outcome Measure Information:
Title
Bad-Outcome Composite Endpoint
Description
Delayed draft function >14 days + never functioning kidney + non-elective readmission before day 90 + surgical complications (wound healing problems, obstructive lymphocele, vascular thrombosis, urinary stenosis or leak, acute hemorrhage, immediate re-intervention) + discharge to an assisted facility + all-cause death.
Time Frame
90 days post-kidney transplantation
Secondary Outcome Measure Information:
Title
Changes in exercise capacity
Description
Changes in peak oxygen uptake (higher scores mean better outcome)
Time Frame
Post-intervention (12 weeks)
Title
Changes in peripheral muscle strength
Description
Changes in handgrip and quadriceps muscles strength (higher scores mean better outcome)
Time Frame
Post-intervention (12 weeks)
Title
Changes in respiratory muscle strength
Description
Changes in maximal inspiratory and expiratory muscle strength (higher scores mean better outcome)
Time Frame
Post-intervention (12 weeks)
Title
Changes in physical activity
Description
Changes in physical activity assessed by activity monitors (higher scores mean better outcome)
Time Frame
Post-intervention (12 weeks)
Title
Attendance
Description
Attended sessions (0-100%, patients are expected to attend a minimum of 80% sessions)
Time Frame
Post-intervention (12 weeks)
Title
Exercise tolerability
Description
Patients not requiring exercise discontinuation or intensity modification
Time Frame
Post-intervention (12 weeks)
Title
Changes in muscle mass
Description
Changes in muscle mass assessed with total body dual energy X-ray
Time Frame
1 month post-KT
Title
Changes in mood state
Description
Changes in Hospital Anxiety Depression Scale
Time Frame
Through study completion, an average of 1 year
Title
Changes in health-related quality of life
Description
Score in the Short-Form 36 questionnaire (8 dimensions scoring 0-100, higher scores mean better outcomes)
Time Frame
Through study completion, an average of 1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults patients with chronic kidney disease
Inclusion in the waiting list for deceased donor kidney transplantation in the period September 2020 to August 2022
Exclusion Criteria:
Patients unable to perform the exercise plan or giving informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ester Marco, MD
Phone
+34699706860
Email
emarco@psmar.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julio Pascual Santos
Organizational Affiliation
Parc de Salut Mar
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital del Mar
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08003
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ester Marco, MD PhD
Phone
+34699706860
Email
emarco@parcdesalutmar.cat
First Name & Middle Initial & Last Name & Degree
Julio Pascual Santos, MD PhD
First Name & Middle Initial & Last Name & Degree
Ester Marco, MD PhD
First Name & Middle Initial & Last Name & Degree
Maria-José Pérez Saez, MD PhD
First Name & Middle Initial & Last Name & Degree
Anna Faura Vendrell, Ns
First Name & Middle Initial & Last Name & Degree
David Benito Guasch, Ns
First Name & Middle Initial & Last Name & Degree
Maria Vera Casanova, Ns
First Name & Middle Initial & Last Name & Degree
Anna Bach Pascual, Ns
First Name & Middle Initial & Last Name & Degree
Montserrat Folgueiras López, Ns
First Name & Middle Initial & Last Name & Degree
Maria D Muns Cornellas, Nutritionist
First Name & Middle Initial & Last Name & Degree
Olga Vázquez Ibar, MD PhD
First Name & Middle Initial & Last Name & Degree
Miguel Garriz Vera, Psychologist
First Name & Middle Initial & Last Name & Degree
Maria Polo Gómez, Psychologist
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34095178
Citation
Perez-Saez MJ, Morgado-Perez A, Faura A, Munoz-Redondo E, Garriz M, Muns MD, Nogues X, Marco E, Pascual J. The FRAILMar Study Protocol: Frailty in Patients With Advanced Chronic Kidney Disease Awaiting Kidney Transplantation. A Randomized Clinical Trial of Multimodal Prehabilitation. Front Med (Lausanne). 2021 May 19;8:675049. doi: 10.3389/fmed.2021.675049. eCollection 2021.
Results Reference
derived
Learn more about this trial
Multimodal Prehabilitation in Frail and Non-frail Patients Waiting for a Kidney Transplantation (the FRAILMAR Study)
We'll reach out to this number within 24 hrs